Tadalafil-associated priapism - 17/08/11
, Maralyn Hallock b, Jared Strote b, Hunter Wessells a, 1
Address for correspondence: Stephen H. King, M.D., University of Washington Medical Center, Department of Urology, 1959 Northeast Pacific Street, Box 356510, Seattle, WA 98195-6510Abstract |
A healthy 46-year-old man presented to the Emergency Department with a 36-hour history of persistent, painful erection after taking the cyclic guanylyl monophosphate-specific phosphodiesterase 5 inhibitor tadalafil. He had no other identified contributing factors for priapism. After confirmation of ischemic priapism and failure of bedside management in the Emergency Department, the patient underwent operative caverno-spongiosal shunting. Postoperatively, the erection initially rebounded but gradually receded with manual compression over 48 hours. At outpatient follow-up, the patient remained flaccid without erections. To our knowledge, this is the first report of tadalafil-associated priapism.
Le texte complet de cet article est disponible en PDF.Plan
Vol 66 - N° 2
P. 432.e15-432.e18 - août 2005 Retour au numéro
Article précédent
- Bladder rupture in premature infant during voiding cystourethrography
- Matthew Wosnitzer, David Shusterman, Joseph G. Barone
- Small cell carcinoma of epididymis: Multimodal therapy
- Guilherme C. Lima, Ioannis M. Varkarakis, Mohamad E. Allaf, Samson W. Fine, Louis R. Kavoussi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?